tak 779 has been researched along with indinavir sulfate in 2 studies
| Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (indinavir sulfate) | Trials (indinavir sulfate) | Recent Studies (post-2010) (indinavir sulfate) |
|---|---|---|---|---|---|
| 118 | 1 | 35 | 1,834 | 328 | 146 |
| Protein | Taxonomy | tak 779 (IC50) | indinavir sulfate (IC50) |
|---|---|---|---|
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (BRU ISOLATE) | 0.0004 | |
| Gag polyprotein | HIV-1 M:B_MN | 0.02 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.2 | |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | 0.0261 | |
| Substance-K receptor | Homo sapiens (human) | 5.101 | |
| Thromboxane-A synthase | Homo sapiens (human) | 1.851 | |
| Protease | Human immunodeficiency virus 1 | 0.0349 | |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.8 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 3.8 | |
| Protease | Human immunodeficiency virus 1 | 0.0044 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, QY; Dong, MX; Jiang, S; Lu, H; Peng, XQ; Yun, LH; Zhang, J | 1 |
| Heil, M; Jones, J; Kutsch, O; Ochsenbauer-Jambor, C; Zammit, KP | 1 |
2 other study(ies) available for tak 779 and indinavir sulfate
| Article | Year |
|---|---|
Tricyclononene carboxamide derivatives as novel anti-HIV-1 agents.
Topics: Anti-HIV Agents; Cell Line; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; HIV-1; Inhibitory Concentration 50; Models, Molecular; Molecular Conformation | 2010 |
T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication.
Topics: Amides; Anti-HIV Agents; Biomarkers; CCR5 Receptor Antagonists; Cell Culture Techniques; Cell Line; Genes, Reporter; Green Fluorescent Proteins; HIV Antibodies; HIV Fusion Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Microbial Sensitivity Tests; Microscopy, Fluorescence; Quaternary Ammonium Compounds; Reverse Transcriptase Inhibitors; RNA, Viral; T-Lymphocytes; Virus Replication | 2006 |